162
Participants
Start Date
February 4, 2010
Primary Completion Date
October 10, 2011
Study Completion Date
December 31, 2025
olaparib
Tablets Oral BID
paclitaxel
175mg/m2 iv for 6 cycles (18 weeks) day 1 of 21 day cycle
carboplatin
AUC6 iv for 6 cycles (18 weeks) day 1 of 21 day cycle
paclitaxel
175mg/m2 iv for up to 6 cycles (18 weeks)
Drug: carboplatin
AUC4 iv for up to 6 cycles (18 weeks)
Research Site, Brussels
Research Site, Randwick
Research Site, Wilrijk
Research Site, Panama City
Research Site, Leuven
Research Site, Parkville
Research Site, Namur
Research Site, New York
Research Site, Torino
Research Site, Genova
Research Site, Monza
Research Site, Milan
Research Site, Hamburg
Research Site, Orlando
Research Site, Solingen
Research Site, Essen
Research Site, Valencia
Research Site, Indianapolis
Research Site, Frankfurt
Research Site, München
Research Site, West Hollywood
Research Site, Stanford
Research Site, Boston
Research Site, Boston
Research Site, Portland
Research Site, Vancouver
Research Site, Hamilton
Research Site, Toronto
Research Site, Toronto
Research Site, Québec
Research Site, Sherbrooke
Research Site, Brno
Research Site, Brno
Research Site, Hradec Králové
Research Site, Olomouc
Research Site, Prague
Research Site, Chūōku
Research Site, Fukuoka
Research Site, Matsuyama
Research Site, Morioka
Research Site, Shinjuku-ku
Research Site, Yamagata
Research Site, Yonago-shi
Research Site, Amsterdam
Research Site, Amsterdam
Research Site, Nijmegen
Research Site, Rotterdam
Research Site, Lima
Research Site, Lima
Research Site, Madrid
Research Site, Birmingham
Research Site, Coventry
Research Site, Edinburgh
Lead Sponsor
AstraZeneca
INDUSTRY